Heel Fat Pad Syndrome Treatment 2026: Cushioning, Orthotics & PRP

The most important risk factor many patients don’t know about is prior cortisone injections into the heel. Corticosteroids are lipolytic — they dissolve fat cells — and repeated injections into the plantar heel fat pad can permanently reduce its volume. This is one reason we are very conservative with cortisone injections for plantar heel conditions. A single well-placed injection is generally safe; multiple injections into the same location over months carry meaningful fat pad atrophy risk.

Other causes and risk factors include: age-related fat pad degeneration (the fat pad loses 50% of its thickness between ages 40–80), chronic repetitive impact from long-distance running on hard surfaces, low body weight and very thin body composition (less fat everywhere, including the heel pad), systemic conditions affecting fat (lupus, rheumatoid arthritis, scleroderma), high-heeled footwear that shifts loading chronically onto the forefoot (paradoxically thinning the heel pad through disuse), diabetes with associated plantar fat pad changes, and prior heel surgery that disrupts fat pad architecture.

How Heel Fat Pad Syndrome Is Diagnosed

Diagnosis is primarily clinical. Examination demonstrates central plantar heel tenderness with direct pressure on the calcaneus — the pain is reproduced by pressing the thumb into the center of the plantar heel rather than at the medial calcaneal tuberosity (plantar fasciitis). Visual inspection may show relative bony prominence of the calcaneus. The “pinch test” — pinching the heel pad from side to side — assesses fat pad thickness and reveals decreased bulk in atrophy.

Ultrasound is the best imaging tool for heel fat pad syndrome — it directly measures fat pad thickness (normal ≥18mm; atrophy <13mm) and assesses internal architecture. MRI shows fat pad signal changes, microtears, and edema within the pad. Weight-bearing lateral X-rays rule out calcaneal stress fractures, heel spurs, and bony pathology. The key differential diagnoses include plantar fasciitis, calcaneal stress fracture (activity-related onset, MRI confirms), calcaneal periostitis, and tarsal tunnel syndrome affecting the inferior calcaneal nerve.

Conservative Treatment for Heel Fat Pad Syndrome

The cornerstone of treatment is replacing the lost shock absorption with external cushioning. Unlike plantar fasciitis, stretching exercises have minimal impact on fat pad syndrome — the problem is structural (tissue thinning), not biomechanical tension. In our clinic, we focus the treatment plan on the three components that actually address the condition: cushioning, load distribution, and activity modification.

Heel cushion cups: Silicone heel cups center and contain the residual fat pad directly under the calcaneus, preventing it from spreading laterally with impact. This is the most cost-effective immediate intervention. Look for cups made from high-density silicone (60–70 Shore A hardness) rather than foam, which compresses and loses effectiveness rapidly. Activity modification: Eliminate running and prolonged standing on hard surfaces during the acute phase. Transition to softer surfaces — grass, track, treadmill — which reduce impact loading by 20–40% compared to concrete. Aqua running and cycling maintain fitness without heel loading. Anti-inflammatory management: NSAIDs provide symptomatic relief. Doctor Hoy’s Natural Pain Relief Gel applied to the plantar heel reduces local inflammation without the fat atrophy risk of cortisone injection. Ice massage (rolling frozen water bottle under foot) for 10 minutes after activity reduces acute inflammation. Footwear optimization: Maximum cushion running shoes (Hoka, Brooks Glycerin, ASICS Gel-Nimbus) provide meaningful heel cushioning. Avoid minimalist shoes and flat dress shoes entirely. A rocker-bottom sole reduces heel peak pressure during gait.

Orthotics and Footwear for Heel Fat Pad Syndrome

Orthotics for heel fat pad syndrome differ from plantar fasciitis orthotics — the focus is heel cushioning and containment, not arch support or fascial tension reduction. The ideal orthotic has a deep heel cup (minimum 16mm), made from cushioning viscoelastic material (Poron, EVA foam) that absorbs impact rather than redirecting it. Carbon fiber rigid devices (common in plantar fasciitis orthotics) are contraindicated — they concentrate impact precisely onto the compromised heel pad.

PowerStep Pinnacle insoles provide a good balance of medial arch support and heel cushioning for patients with combined flat foot and fat pad syndrome. CURREX RunPro insoles are preferred for runners because of their dynamic energy return properties and heel cup depth. Custom orthotics are indicated when over-the-counter options fail — they can be prescribed with specific heel cushion additions and unloading modifications that standard insoles cannot provide.

Cortisone Injections: What Heel Fat Pad Patients Must Know

Cortisone injection is appropriate for plantar fasciitis but requires extreme caution for heel fat pad syndrome. Corticosteroids are lipolytic — they dissolve fat tissue — and an injection placed into the already atrophied fat pad can further reduce its volume, worsening the long-term condition even as it temporarily reduces pain. In our clinic, we do not inject cortisone into the center of the plantar heel for confirmed fat pad syndrome. If inflammatory component is present, alternative anti-inflammatory approaches are used.

Platelet-rich plasma (PRP) injection shows emerging promise for heel fat pad syndrome — PRP growth factors promote fat cell differentiation and collagen reorganization within the pad. Small studies show measurable ultrasound improvement in fat pad thickness at 6 months post-injection. It remains an off-label application but is a reasonable consideration for patients with confirmed atrophy who have failed conservative care and need more than symptom management.

The Most Common Mistake with Heel Fat Pad Syndrome

The most common mistake is treating fat pad syndrome with plantar fasciitis protocols — calf stretches, night splints, and plantar fascia stretching — which provide no benefit because the pathology is structural thinning, not fascial tension. Patients spend months with no improvement because the treatment targets the wrong tissue. The second critical mistake is repeated cortisone injections into the heel for “plantar fasciitis” in a patient who actually has fat pad syndrome. Each injection further thins the fat pad, creating a worsening cycle where the “treatment” is causing the disease. Any patient who has had 3 or more plantar heel cortisone injections and continues to have central heel pain should be evaluated for fat pad atrophy before another injection is considered.

Recommended Products

Frequently Asked Questions

Sources

1. Wearing SC, Smeathers JE, Urry SR, Hennig EM, Hills AP. The pathomechanics of plantar fasciitis. Sports Med. 2006;36(7):585–611.
2. Ozdemir H, Söyuncu Y, Ozgorgen M, Dabak K. Effects of changes in heel fat pad thickness and elasticity on heel pain. J Am Podiatr Med Assoc. 2004;94(1):47–52.
3. Rome K, Campbell R, Flint A, Haslock I. Heel pad thickness — a contributing factor associated with plantar heel pain in young adults. Foot Ankle Int. 2002;23(2):142–147.
4. Hsu CC, Tsai WC, Wang CL, Pao SH, Shau YW, Chung CY. Microchambers and macrochambers in heel pads: are they functionally different? J Appl Physiol. 2007;102(6):2227–2231.

Dr. Tom Biernacki, DPM

Dr. Tom Biernacki, DPM is a double board-certified podiatrist and foot & ankle surgeon at Balance Foot & Ankle Specialists in Southeast Michigan. With over a decade of clinical experience, he specializes in heel pain, bunions, diabetic foot care, sports injuries, and minimally invasive surgery. Dr. Biernacki is a member of the APMA and ACFAS, and his patient education content on MichiganFootDoctors.com and YouTube has reached over one million views.